January 28, 2025 · Form 4 insider transaction
Sabag Mark bought 183,169 shares of Teva Pharmaceutical Industries Limited at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.; Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 4, 2025.; The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.